Skip to content

Management of Orthoplastic combined ERAS in severe open fractureand the underlying molecular mechanism of infection

Management of Orthoplastic combined ERAS in severe open fractureand the underlying molecular mechanism of infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115604
Enrollment
Unknown
Registered
2025-12-29
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe open fracture

Interventions

control group:The control group underwent routine one-stage treatment, which included thorough debridement, fixation of fractures with external fixation braces, and coverage of the wound with VSD. In
Orthoplastic group:The orthopedic team will complete thorough debridement in the first stage, followed by minimally invasive percutaneous plate osteosynthesis or intramedullary nailing for fracture fi
Orthoplastic+ERAS group:After admission, the patient received preoperative education and psychological counseling under the ERAS concept, and received multimodal analgesia to increase patient comfort.

Sponsors

Zhuzhou central hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Gustilo type IIIB and C fractures (wound >10cm, extensive soft tissue loss with or without vascular injury requiring repair, extensive periosteal detachment, poor fracture coverage, heavy wound contamination, requiring wound repair); 2 All cases were diagnosed through imaging examinations such as X-ray and CT; 3 Patients with fresh fractures (fractures occurred within 6 hours); 4 Individuals without other infectious diseases; 5 Individuals with no history of mental illness and normal cognitive abilities; 6 Those who voluntarily participate and sign the informed consent form, and are able to cooperate and complete the entire trial process.

Exclusion criteria

Exclusion criteria: 1 Patients with closed fractures and pathological fractures; 2 Patients with severe multiple injuries (ISS = 16 points); 3 Patients with hepatic and renal insufficiency, and abnormal coagulation function; 4 Patients with malignant tumors; 5 Patients with severe underlying diseases; 6 Those who have undergone surgery on the affected limb.

Design outcomes

Primary

MeasureTime frame
X-ray and CT scans show the healing status of bones;Knee joint function score (HSS), ankle joint Kofoed score, and Johner-Wruhs score;

Secondary

MeasureTime frame
Wound healing area and wound healing quality;Number and positivity rate of pathogenic bacteria infection, levels of inflammatory factors (C-reactive protein, white blood cell count, interleukin-6, tumor necrosis factor alpha, and erythrocyte sedimentation rate);

Countries

China

Contacts

Public ContactEryue Qiu

Zhuzhou central hospital

691737252@qq.com+86 153 6420 0881

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026